Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AVITA Medical Inc RCEL

Healthcare Biotechnology
AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a provider of regenerative medicine addressing unmet medical needs in burn injuries, full-thickness skin defects, and in skin repigmentation, such as vitiligo. Its RECELL platform a single use, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile... see more

Recent & Breaking News (NDAQ:RCEL)

AVITA Medical to Present at RBC Capital Markets 2019 Healthcare Conference

Business Wire May 1, 2019

AVITA Medical Third Quarter Fiscal 2019 Quarterly Cash Flow Report and Company Update

Business Wire April 29, 2019

AVITA Medical Announces Presentation at ABA Meeting Highlighting Results of Study Using RECELL® System to Treat Third-Degree Burns in Pediatric Patients

Business Wire April 7, 2019

AVITA Medical RECELL® System Health Economic Data Project USD $28 Million in Annual Savings at a Single Major Burn Center Versus Standard of Care

Business Wire April 4, 2019

AVITA Medical to Present at Cowen and Company Health Care Conference

Business Wire March 12, 2019

AVITA Medical Announces Ten RECELL® System Presentations at the American Burn Association (ABA) Annual Meeting

Business Wire March 10, 2019

Avita Medical Announces Collaboration with COSMOTEC, an M3 Group Company, to Commercialize the RECELL® System in Japan

Business Wire March 3, 2019

AVITA Medical Announces Temporary Interruption of Sales of Products in EU

Business Wire March 3, 2019

Avita Medical Half-Year Financial Report for Fiscal 2019

Business Wire February 27, 2019

Avita Medical Second Quarter Fiscal 2019 Quarterly Cash Flow Report and Company Update

Business Wire January 30, 2019

AVITA Medical Announces Nine RECELL® System Abstracts Accepted for Presentation at American Burn Association (ABA) 51st Annual Meeting

Business Wire January 28, 2019

AVITA Medical Announces U.S. National Market Launch of RECELL® System

Business Wire January 7, 2019

AVITA Medical Named One of the Most Innovative Companies of 2018 by PM360

Business Wire December 19, 2018

AVITA Medical Announces Receipt of A$1.4 Million Research and Development Tax Credit

Business Wire December 17, 2018

AVITA Medical Announces Institutional Placement of A$40.0 Million to Support Commercialization and Pipeline Advancement

Business Wire December 4, 2018

AVITA Medical Announces Hiring of Full U.S. Sales Team of Experienced Burn Professionals to Support National Launch of RECELL® System

Business Wire November 15, 2018

Leading Burn Surgeons Present Positive RECELL® System Results at 31st Annual Southern Region Burn CME Conference and Northeast Region Burn Conference

Business Wire November 13, 2018

Avita Medical First Quarter Fiscal 2019 Quarterly Cash Flow Report and Company Update

Business Wire October 31, 2018

AVITA Medical Announces Commencement of Randomized Controlled Clinical Study of RECELL® System in Treatment of Children with Burn Injuries

Business Wire October 24, 2018

AVITA Medical Announces First U.S. Sales of RECELL® System and Commencement of Commercial Shipping

Business Wire October 17, 2018